1. Home
  2. NREF vs FENC Comparison

NREF vs FENC Comparison

Compare NREF & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NREF
  • FENC
  • Stock Information
  • Founded
  • NREF 2019
  • FENC 1996
  • Country
  • NREF United States
  • FENC United States
  • Employees
  • NREF N/A
  • FENC N/A
  • Industry
  • NREF Real Estate Investment Trusts
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NREF Real Estate
  • FENC Health Care
  • Exchange
  • NREF Nasdaq
  • FENC Nasdaq
  • Market Cap
  • NREF 244.3M
  • FENC 222.9M
  • IPO Year
  • NREF 2020
  • FENC 2001
  • Fundamental
  • Price
  • NREF $13.77
  • FENC $8.18
  • Analyst Decision
  • NREF Hold
  • FENC Strong Buy
  • Analyst Count
  • NREF 3
  • FENC 2
  • Target Price
  • NREF $14.50
  • FENC $13.00
  • AVG Volume (30 Days)
  • NREF 43.8K
  • FENC 53.1K
  • Earning Date
  • NREF 07-31-2025
  • FENC 08-12-2025
  • Dividend Yield
  • NREF 14.49%
  • FENC N/A
  • EPS Growth
  • NREF N/A
  • FENC N/A
  • EPS
  • NREF 2.60
  • FENC N/A
  • Revenue
  • NREF $123,447,000.00
  • FENC $30,912,000.00
  • Revenue This Year
  • NREF $27.69
  • FENC $0.85
  • Revenue Next Year
  • NREF $5.49
  • FENC $55.16
  • P/E Ratio
  • NREF $5.30
  • FENC N/A
  • Revenue Growth
  • NREF 337.68
  • FENC N/A
  • 52 Week Low
  • NREF $12.14
  • FENC $3.96
  • 52 Week High
  • NREF $18.09
  • FENC $9.30
  • Technical
  • Relative Strength Index (RSI)
  • NREF 42.07
  • FENC 42.85
  • Support Level
  • NREF $14.30
  • FENC $8.41
  • Resistance Level
  • NREF $14.58
  • FENC $8.94
  • Average True Range (ATR)
  • NREF 0.31
  • FENC 0.34
  • MACD
  • NREF 0.02
  • FENC -0.08
  • Stochastic Oscillator
  • NREF 4.67
  • FENC 0.00

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: